Tully Phillip J, Harrison Nathan J, Cheung Peter, Cosh Suzanne
Bordeaux Population Health, University of Bordeaux, U1219, Bordeaux, France.
Freemasons Foundation Centre for Men's Health, Discipline of Medicine, The University of Adelaide, Adelaide, Australia.
Curr Cardiol Rep. 2016 Dec;18(12):120. doi: 10.1007/s11886-016-0800-3.
Unrecognized anxiety is a difficult clinical presentation in cardiology. Anxiety leads to recurring emergency department visits and the need for numerous diagnostic evaluations to rule out cardiovascular disease (CVD). This review focuses broadly on anxiety and its subtypes in relation to the onset and progression of CVD while describing helpful guidelines to better identify and treat anxiety. Potential mechanisms of cardiopathogenesis are also described. An emerging literature demonstrates that anxiety disorders increase the risk for incident CVD but a causal relationship has not been demonstrated. Anxiety portends adverse prognosis in persons with established CVD that is independent from depression. The level of clinical priority received by depression should be extended to research and clinical intervention efforts in anxiety. Anxiety holds direct relevance for uncovering mechanisms of cardiopathogenesis, developing novel therapeutic strategies, and initiating clinical interventions in the population at risk of developing heart disease, or those already diagnosed with CVD.
未被识别的焦虑在心脏病学中是一种棘手的临床表现。焦虑导致反复前往急诊科就诊,并且需要进行大量诊断评估以排除心血管疾病(CVD)。本综述广泛关注焦虑及其亚型与CVD发病和进展的关系,同时描述有助于更好地识别和治疗焦虑的实用指南。还描述了心脏发病机制的潜在机制。新出现的文献表明,焦虑症会增加发生CVD的风险,但尚未证实存在因果关系。焦虑预示着已患CVD者的不良预后,且这种预后与抑郁症无关。对抑郁症给予的临床重视程度应扩展到焦虑症的研究和临床干预工作中。焦虑对于揭示心脏发病机制、开发新的治疗策略以及对有患心脏病风险的人群或已被诊断患有CVD的人群开展临床干预具有直接相关性。